Detalles de la búsqueda
1.
Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.
Am J Nephrol
; 53(6): 446-454, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35551374
2.
Real-world assessment: effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patients.
BMC Nephrol
; 23(1): 362, 2022 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368937
3.
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
Am J Nephrol
; 49(4): 284-293, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30878999
4.
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.
Am J Nephrol
; 44(4): 316-325, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27676085
5.
Extended-Release Calcifediol: A Data Journey From Phase 3 Studies to Real-world Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism.
Nephron
; 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657576
6.
Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease.
Kidney Dis (Basel)
; 9(3): 206-217, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37497207
7.
REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatients.
Nutrition
; 107: 111899, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36529089
8.
Differential effects of oral doxercalciferol (Hectorol) or paricalcitol (Zemplar) in the Cyp27b1-null mouse model of uremia.
Nephron Exp Nephrol
; 119(3): e67-74, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21849802
9.
Comparison of active vitamin D compounds and a calcimimetic in mineral homeostasis.
J Am Soc Nephrol
; 21(10): 1713-23, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20651168
10.
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.
Am J Physiol Renal Physiol
; 297(3): F791-801, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19535571
11.
Evidence for the activation of 1alpha-hydroxyvitamin D2 by 25-hydroxyvitamin D-24-hydroxylase: delineation of pathways involving 1alpha,24-dihydroxyvitamin D2 and 1alpha,25-dihydroxyvitamin D2.
Biochim Biophys Acta
; 1761(2): 221-34, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16516540
12.
Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
Expert Rev Endocrinol Metab
; 12(5): 289-301, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30058895
13.
Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs.
Anticancer Res
; 26(4A): 2589-95, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16886668
14.
Use of vitamin D(4) analogs to investigate differences in hepatic and target cell metabolism of vitamins D(2) and D(3).
Biochim Biophys Acta
; 1583(2): 151-66, 2002 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-12117559
15.
1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors.
Anticancer Res
; 25(1A): 235-41, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15816543
16.
Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation.
J Steroid Biochem Mol Biol
; 148: 283-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25446887
17.
Tissue distribution and activity studies of 1,24-dihydroxyvitamin D2, a metabolite of vitamin D2 with low calcemic activity in vivo.
Biochem Pharmacol
; 68(7): 1289-96, 2004 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15345318
18.
Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model.
Arch Ophthalmol
; 122(9): 1365-9, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15364717
19.
Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models.
Arch Ophthalmol
; 122(9): 1357-62, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15364716
20.
Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model.
Arch Ophthalmol
; 120(5): 607-12, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12003610